Literature DB >> 25583053

Recognition and significance of pathological T-wave inversions in athletes.

Frédéric Schnell1, Nathan Riding1, Rory O'Hanlon1, Pierre Axel Lentz1, Erwan Donal1, Gaelle Kervio1, David Matelot1, Guillaume Leurent1, Stéphane Doutreleau1, Laurent Chevalier1, Sylvain Guerard1, Mathew G Wilson1, François Carré2.   

Abstract

BACKGROUND: Pathological T-wave inversion (PTWI) is rarely observed on the ECG of healthy athletes, whereas it is common in patients with certain cardiac diseases. All ECG interpretation guidelines for use within athletes state that PTWI (except in leads aVR, III and V1 and in V1-V4 when preceded by domed ST segment in asymptomatic Afro-Caribbean athletes only) cannot be considered a physiological adaptation. The aims of the present study were to prospectively determine the prevalence of cardiac pathology in athletes presenting with PTWI, and to examine the efficacy of cardiac magnetic resonance in the work-up battery of further examinations. METHODS AND
RESULTS: Athletes presenting with PTWI (n=155) were investigated with clinical examination, ECG, echocardiography, exercise testing, 24h Holter ECG, and cardiac magnetic resonance. Cardiac disease was established in 44.5% of athletes, with hypertrophic cardiomyopathy (81%) the most common pathology. Echocardiography was abnormal in 53.6% of positive cases, and cardiac magnetic resonance identified a further 24 athletes with disease. Five athletes (7.2%) considered normal on initial presentation subsequently expressed pathology during follow-up. Familial history of sudden cardiac death and ST-segment depression associated with PTWI were predictive of cardiac disease.
CONCLUSIONS: PTWI should be considered pathological in all cases until proven otherwise, because it was associated with cardiac pathology in 45% of athletes. Despite echocardiography identifying pathology in half of these cases, cardiac magnetic resonance must be considered routine in athletes presenting with PTWI with normal echocardiography. Although exclusion from competitive sport is not warranted in the presence of normal secondary examinations, annual follow-up is essential to ascertain possible disease expression.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy, hypertrophic

Mesh:

Year:  2014        PMID: 25583053     DOI: 10.1161/CIRCULATIONAHA.114.011038

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Sudden Cardiac Arrest during Participation in Competitive Sports.

Authors:  Cameron H Landry; Katherine S Allan; Kim A Connelly; Kris Cunningham; Laurie J Morrison; Paul Dorian
Journal:  N Engl J Med       Date:  2017-11-16       Impact factor: 91.245

Review 2.  Hypertrophic Cardiomyopathy in Athletes.

Authors:  Aneil Malhotra; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2017-12

Review 3.  Abnormal ECG Findings in Athletes: Clinical Evaluation and Considerations.

Authors:  Mark Abela; Sanjay Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-21

Review 4.  Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease.

Authors:  Giovanni Quarta; Michael Papadakis; Paolo Di Donna; Niccolò Maurizi; Attilio Iacovoni; Antonello Gavazzi; Michele Senni; Iacopo Olivotto
Journal:  Nat Rev Cardiol       Date:  2016-11-10       Impact factor: 32.419

Review 5.  Left Ventricular Hypertrophy in Athletes: Differentiating Physiology From Pathology.

Authors:  Daniel X Augustine; Liz Howard
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-10-26

6.  Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA.

Authors:  Daniele Massera; Robyn L McClelland; Bharath Ambale-Venkatesh; Antoinette S Gomes; W Gregory Hundley; Nadine Kawel-Boehm; Kihei Yoneyama; David S Owens; Mario J Garcia; Mark V Sherrid; Jorge R Kizer; Joao A C Lima; David A Bluemke
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

Review 7.  Hypertrophic Cardiomyopathy: Updates Through the Lens of Sports Cardiology.

Authors:  Bradley S Lander; Dermot M Phelan; Matthew W Martinez; Elizabeth H Dineen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-25

8.  Frequency of Electrocardiographic Changes in Trained Athletes in the Republic of Macedonia.

Authors:  Ivanka Karagjozova; Suncica Petrovska; Slobodan Nikolic; Vesela Maleska-Ivanovska; Ljubica Georgievska-Ismail
Journal:  Open Access Maced J Med Sci       Date:  2017-10-06

Review 9.  The congenital long QT syndrome Type 3: An update.

Authors:  Andrés Ricardo Pérez-Riera; Raimundo Barbosa-Barros; Rodrigo Daminello Raimundo; Marianne Penachini da Costa de Rezende Barbosa; Isabel Cristina Esposito Sorpreso; Luiz Carlos de Abreu
Journal:  Indian Pacing Electrophysiol J       Date:  2017-10-31

10.  Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion.

Authors:  Nabeel Sheikh; Michael Papadakis; Mathew Wilson; Aneil Malhotra; Carmen Adamuz; Tessa Homfray; Lorenzo Monserrat; Elijah R Behr; Sanjay Sharma
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.